🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Second year fellow, Tali Azenkot, presented her work with mentor, Sandip Patel MD FASCO, at AACR last week! This study evaluated the use of a combined mutation/methylation cfDNA assay for tumor-independent cancer monitoring in NSCLC. Congratulations, Tali and Dr. Patel! 🫁 #AACR25

#ASCO25 is just a few days away! At 📍Marriott Marquis, May 31, 6:30-9PM, lets discuss the current SoC & practice changing/reinforcing data! ✅ Register: bit.ly/aioasco25 #AdvInOnc25 #OncTwitter #bcsm #lcsm #gism #gusm #MedTwitter SignifyMD

Great to have new protein targeting ADCs (teliso-V for high MET in refractory NSCLC most recently), but one issue is we lack of liquid biopsy or multiplex platform for all the IHc targets we need (HER2, MET, PD-L1) and likely others upcoming. Multiplex/dig path solutions here.

We asked 5 top lung cancer experts which #ASCO2025 presentations are a must-see—and why. 🎙️ Featuring: Joshua Sabari, MD, Sandip Patel MD FASCO, Susan Combs Scott, MD, Desai, & Qin 👉 Get their picks—sign up for exclusive access! hubs.li/Q03nrrcy0

Flatiron analysis of 34,510 pts with NSCLC on biomarker testing JCO Oncology Practice by Sandip Patel MD FASCO. Steady rise in biomarker testing: in 2023, 89% tested for #EGFR and 88% for #ALK. Not all receive targeted therapy though: only 84% of ALK+ receive an ALK TKI. ascopubs.org/doi/10.1200/PO…

🌊 Sun, science, and the sharpest minds in lung cancer care. Hear from Sandip Patel MD FASCO on why the 26th Annual ILCC this July 25-26 is where you need to be! 🏄Join the experts in Huntington Beach, CA: tinyurl.com/ra9reu3z #gotoPER #ILCC25

Please join Alex A. Adjei #DrRebeccaHeist and myself ASCO on 5/30 630p CST at Sheraton Grand Chicago Riverwalk for a great discussion around MET targeted in NSCLC PER

Looking forward to a great ASCO Educational Session on utilizing artificial intelligence to accelerated oncology clinical trials with perspectives from FDA and FNIH on 5/30 430pm CST in S102, please join us for this pan-institutional discussion

Artificial Intelligence and Machine Learning Innovations to Improve Design and Representativeness in Oncology Clinical Trials | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.12… #ASCO25

Looking forward to @asco later this week! Avoid the traffic when heading to the loop and take a shuttle or the Metra train which runs from inside McCormick to Millennium station. Conquer Cancer, the ASCO Foundation kindly sponsors a free digital Metra ticket

In light of recent induction toripalumab induction in stage III NSCLC from iNTRist (ASCO25 8012) nice review from ⁦ASCO⁩ Post led by my fellow ⁦Tali Azenkot⁩ —CRT Fits Into the Treatment Landscape of LA-NSCLC ⁦UC San Diego Health Moores Cancer Center dailynews.ascopubs.org/do/evaluating-…

🤖 Accelerating Cancer Clinical Trials With AI AI is revolutionizing oncology trials—from smarter design to equitable recruitment Join us to explore how machine learning enhances trial diversity, patient matching & early detection of outcomes #ASCO25 Sandip Patel MD FASCO

Thanks OncLive.com for this awesome program for fellows! The future of thoracic oncology is bright! #meded #ASCO25 Narjust Florez, MD, FASCO Sandip Patel MD FASCO Benjamin Levy Eric K. Singhi, MD Kristen A. Marrone, MD

Exciting insights at #ASCO25! The session "Accelerating Cancer Clinical Trials With Artificial Intelligence."

🎉Congrats to Dr. Sandip Patel, Cancer's Developmental Therapeutics & Social Media Editor, & ASCO Fellow, on receipt of his #ASCO25 Award later this morning! 🏆 See his recent work on immunotx for advanced gallbladder cancer: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Sandip Patel MD FASCO

Congratulations Sandip Patel MD FASCO, one of the newest members of LUNGevity's Scientific Advisory Board. We are grateful for your expertise and leadership.

Cop on Artifical Intelligence Ravi B. Parikh Sandip Patel MD FASCO

Sandip Patel MD FASCO joins Caroline Chung, MD and Ravi B. Parikh to discuss the role of #AI in clinical trials. They discuss the importance for engagment as how to balance #equitable and #ethical use of #AI. U.S. FDA regulation vs guidance discussed. They expand further in an ASCO #Edbook 📗

Great (free) article in ASCO Educational Book on innovations and best practices for AI use in oncology and clinical trials by UCSD Fellow Tali Azenkot ; ascopubs.org/doi/pdf/10.120…